CENTENNIAL, Colo.-Nationally, prostate cancer is the second most common major cancer among men, and according to the North Dakota Statewide Cancer Registry, it was the most commonly occurring cancer ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

A new web-based tool utilizing AI can help pathologists detect prostate cancer faster, say Northeastern University researchers who developed the technology. Prostate cancer is the most common cancer ...

This undated microscope image provided by the National Institutes of Health shows cancer cells with the cell nuclei stained red. The U.S. Food and Drug Administration approved the use of Paige ...

Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...

When U.S. Sen. Bob Casey of Pennsylvania courageously shared his prostate cancer diagnosis and surgery earlier this year, he credited the support of his family and his exceptional medical care for his ...

A common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have warned. The digital rectal exam (DRE) is widely used by medical ...

JACKSONVILLE, Fla. – UF Health in Jacksonville is using a new tool to help doctors diagnose prostate cancer. Dr. Shahla Masood, who is the chair of UF Health Jacksonville’s Department of Pathology and ...

(CNN) — Editor’s note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and past president of the Florida Urological Society. Prostate cancer remains a significant concern ...

Source: Getty Images A new predictive model based on artificial intelligence identifies men who will and will not benefit from adding androgen deprivation therapy to radiation therapy for intermediate ...

ANN ARBOR, Michigan — A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a new study finds. For patients enrolled in Medicare Part D ...